All In Biotech

Drug Trial Radar · NCT06492616

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Elacestrant Versus Standard Endocrine Therapy in Women and Men With Node-positive, Estrogen Receptor-positive, HER2-negative, Early Breast Cancer With High Risk of Recurrence-A Global, Multicenter, Randomized, Open-label Phase 3 Study

Last checked: Nov 19, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 4,556 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

4,556

Actual

Start

Sep 27, 2024

Primary completion

Aug 2029

Study completion Oct 2032

Sponsor

Lead sponsor
Stemline Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Jul 9, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary goal of this study is to evaluate the effectiveness of elacestrant versus standard endocrine therapy in participants with node-positive, Estrogen Receptor-positive (ER+), Human Epidermal Growth Factor-2 negative (HER2-) early breast cancer with high risk of recurrence.

Conditions

  • Breast Cancer

Interventions

  • ElacestrantDrug

    Administered as oral tablets

  • AnastrozoleDrug

    Administered as oral tablets

  • LetrozoleDrug

    Administered as oral tablets

  • ExemestaneDrug

    Administered as oral tablets

  • TamoxifenDrug

    Administered as oral tablets

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Invasive Breast Cancer-Free Survival (IBCFS)Time frame: Up to 5 years

Locations

555 sites in 28 countries. Site status is shown where the registry gives one.

  • Southern Cancer Center, PC

    Daphne, Alabama

  • Ironwood Cancer and Research Centers

    Chandler, Arizona

  • Banner MD Anderson Cancer Center

    Gilbert, Arizona

  • Banner University Medical Center - Phoenix Campus (Banner Good Samaritan Medical Center)

    Phoenix, Arizona

  • Mayo Clinic

    Scottsdale, Arizona

  • Arizona Clinical Research Center, Inc.

    Tucson, Arizona

  • University of Arizona Cancer Center

    Tucson, Arizona

  • Highlands Oncology Group, PA

    Springdale, Arkansas

  • UCSF Cancer Center Berkeley

    Berkeley, California

  • Cedars-Sinai Cancer Beverly Hills

    Beverly Hills, California

  • City of Hope National Medical Center

    Duarte, California

  • UCSF Wash Cancer CNTR

    Fremont, California

  • City of Hope at Irvine Lennar

    Irvine, California

  • UC San Diego Moores Cancer Center

    La Jolla, California

  • Helios Clinical Research

    Long Beach, California

  • Cancer and Blood Research Center, LLC

    Los Alamitos, California

  • USC/Norris Comprehensive Cancer Center

    Los Angeles, California

  • UCLA Department of Medicine - Hematology/Oncology

    Los Angeles, California

  • Pacific Cancer Care - Oncology

    Monterey, California

  • Hoag Memorial Hospital Presbyterian

    Newport Beach, California

  • UC Irvine Health, Chao Family Comprehensive Cancer Center

    Orange, California

  • Stanford Women's Cancer Center

    Palo Alto, California

  • Dignity Health dba Health Research Institute

    Sacramento, California

  • Sutter Institute for Medical Research

    Sacramento, California

  • UCSF Zuckerberg SF General

    San Francisco, California

  • University of California, San Francisco (UCSF)

    San Francisco, California

  • Southern California Kaiser Medical Center-San Marcos Medical

    San Marcos, California

  • UCSF Cancer Center San Mateo

    San Mateo, California

  • Sansum Clinic

    Solvang, California

  • Torrance Memorial Physician Network- Cancer Care

    Torrance, California

  • St. Joseph Hospital-Cancer Centers of Colorado

    Denver, Colorado

  • Rocky Mountain Cancer Centers, LLP

    Lone Tree, Colorado

  • AHMG Hematology and Oncology

    Parker, Colorado

  • Yale New Haven Hospital- Yale Cancer Center

    New Haven, Connecticut

  • Georgetown University Medical Center

    Washington D.C., District of Columbia

  • MedStar Washington Hospital Center

    Washington D.C., District of Columbia

  • Sibley Memorial Hospital

    Washington D.C., District of Columbia

  • The George Washington Medical Faculty Associates

    Washington D.C., District of Columbia

  • Florida Cancer Specialists

    Fort Myers, Florida

  • Mayo Clinic

    Jacksonville, Florida

Showing 40 of 555 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.